Many companies including Amazon received DGCI notice, know what is the whole matter


Business News Desk,The Drug Controller General of India has issued notices to 20 e-pharma companies operating across the country. The drug regulator of India has issued notices to these companies for violation of the Drugs and Cosmetics Act, 1940. According to the report published in Money Control, DGCI VJ Somani has asked in the notice that the court has banned in the last several years. Many times the sale of drugs online.

Know which companies have been issued notice-
Significantly, in case of violation of rules, DGCI has issued show cause notices to 20 companies like Tata 1mg, Flipkart Health Plus (Flipkart Health+) and Amazon (Amazon). At present, no company has given any official statement on this notice. DGCI has said in its notice that selling medicines online without a valid DGCI license has a very bad effect on its quality. In such a situation, keeping in mind the health of the people, DGCI has taken this step.

Companies will have to answer in two days
In its notice, the Drug Controller has given two days to companies selling medicines online and through the Internet like Tata 1mg, Flipkart Health+ and Amazon. If the companies do not respond to this notice sent to DGCI during this period, it will be assumed that they have no response in the matter. After this, DGCI will take action as per law. Let us tell you that a few days ago the Delhi High Court found three e-pharmacies selling medicines without valid DGCI license and directed the Drug Controller to take action in this matter.

Share this story

Leave a Comment